Both in Pharmaceuticals
Pyxis Oncology vs Journey Medical
Over the past year PYXS returned −57.0% and DERM returned −45.5%; their daily moves had a correlation of 0.08.
PYXS −57.0% DERM −45.5%Growth of $1, one year, split-adjusted
| Metric | PYXS | DERM |
|---|---|---|
| Price | $1.64 | $4.64 |
| Market cap | $136.8M | $131.0M |
| Today | −2.96% | −3.13% |
| 1 month | −26.8% | −30.6% |
| 6 months | −10.4% | −10.4% |
| Year to date | +42.6% | −39.8% |
| 1 year | −53.9% | −42.9% |
| Revenue growth (YoY) | −100.0% | +18.9% |
| Gross margin | — | 65.6% |
| Net margin | — | −1.7% |
| P/E (TTM) | — | — |
| Price / sales | 12.4× | 2.0× |
| Net cash | $33.0M | -$245.0K |
| Dividend yield | — | — |
| Volatility (60d) | 112.4% | 64.3% |
| Short % of float | 7.9% | 24.8% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).